Noked Israel’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Noked Israel’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,051	Closed	-$4K	–	60
2022 Q2	$4K	Hold	18,051	–	–	﹤0.01%	48
2022 Q1	$18K	Buy	+18,051	New	+$16K	0.01%	42

Other funds holding CTV.WS

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

IAC

ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Noked Israel's CTV.WS Position: Q3 2022 in Review

Noked Israel sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q3 2022, closing a stake of 18,051 shares — an estimated $4K sold.

Noked Israel first reported a position in CTV.WS in Q1 2022 and held it in 2 quarters. The position peaked at $18K in Q1 2022. 22 funds tracked by Wall St. Rank hold CTV.WS as of Q3 2022.

Noked Israel reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
Noked Israel sold 18,051 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q3 2022, an estimated $4K.
Noked Israel first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 2 quarters.
Noked Israel's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $18K in Q1 2022.
22 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q3 2022.

Based on Noked Israel's 13F filing for Q3 2022, filed 14 Nov 2022.